Peritoneal dialysis and heart failure.

IF 3.1 3区 医学 Q3 PERIPHERAL VASCULAR DISEASE
Caroline M Hsu, Daniel E Weiner, Wendy McCallum
{"title":"Peritoneal dialysis and heart failure.","authors":"Caroline M Hsu, Daniel E Weiner, Wendy McCallum","doi":"10.1097/MNH.0000000000001125","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Heart failure and chronic kidney disease are frequently comorbid, with both characterized by salt and water retention that lead to clinical deterioration. Peritoneal dialysis can effectively treat fluid overload and maintain euvolemia but remains underutilized. This review addresses the use of peritoneal dialysis in heart failure, including its potential advantages and also its challenges.</p><p><strong>Recent findings: </strong>The 2019 Advancing American Kidney Health initiative incentivized increased use of peritoneal dialysis in the United States. There is, therefore, growing recognition of peritoneal dialysis's appropriateness for heart failure, in that it can effectively remove volume, often with greater hemodynamic stability than intermittent hemodialysis. Peritoneal dialysis additionally avoids the risk of systemic bloodstream infection, which may be particularly high risk for patients with cardiac devices. System and logistic challenges remain for more widespread uptake of peritoneal dialysis in people with kidney failure and heart failure, including limited ability to urgently start peritoneal dialysis and clinician and hospital inexperience.</p><p><strong>Summary: </strong>Peritoneal dialysis is an effective therapy for heart failure in individuals with kidney failure but remains underutilized. Strategies for increased uptake include provider education and greater structural and logistic support, particularly in the inpatient setting.</p>","PeriodicalId":10960,"journal":{"name":"Current Opinion in Nephrology and Hypertension","volume":" ","pages":"118-125"},"PeriodicalIF":3.1000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12820935/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Nephrology and Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MNH.0000000000001125","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Heart failure and chronic kidney disease are frequently comorbid, with both characterized by salt and water retention that lead to clinical deterioration. Peritoneal dialysis can effectively treat fluid overload and maintain euvolemia but remains underutilized. This review addresses the use of peritoneal dialysis in heart failure, including its potential advantages and also its challenges.

Recent findings: The 2019 Advancing American Kidney Health initiative incentivized increased use of peritoneal dialysis in the United States. There is, therefore, growing recognition of peritoneal dialysis's appropriateness for heart failure, in that it can effectively remove volume, often with greater hemodynamic stability than intermittent hemodialysis. Peritoneal dialysis additionally avoids the risk of systemic bloodstream infection, which may be particularly high risk for patients with cardiac devices. System and logistic challenges remain for more widespread uptake of peritoneal dialysis in people with kidney failure and heart failure, including limited ability to urgently start peritoneal dialysis and clinician and hospital inexperience.

Summary: Peritoneal dialysis is an effective therapy for heart failure in individuals with kidney failure but remains underutilized. Strategies for increased uptake include provider education and greater structural and logistic support, particularly in the inpatient setting.

腹膜透析和心力衰竭。
综述目的:心力衰竭和慢性肾脏疾病经常是合并症,两者都以盐和水潴留为特征,导致临床恶化。腹膜透析可以有效地治疗液体超载和维持血液充血,但仍未得到充分利用。本文综述了腹膜透析在心力衰竭中的应用,包括其潜在的优势和挑战。最近的发现:2019年推进美国肾脏健康倡议鼓励在美国增加腹膜透析的使用。因此,越来越多的人认识到腹膜透析对心力衰竭的适用性,因为它可以有效地去除容量,通常比间歇性血液透析具有更高的血流动力学稳定性。腹膜透析还可以避免全身血流感染的风险,这对于装有心脏装置的患者来说可能是特别高的风险。对于肾衰竭和心力衰竭患者腹膜透析的广泛应用,系统和后勤方面的挑战仍然存在,包括紧急开始腹膜透析的能力有限以及临床医生和医院缺乏经验。摘要:腹膜透析是治疗肾衰竭患者心衰的有效方法,但仍未得到充分利用。提高吸收的战略包括提供者教育和加强结构和后勤支助,特别是在住院环境中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Opinion in Nephrology and Hypertension
Current Opinion in Nephrology and Hypertension 医学-泌尿学与肾脏学
CiteScore
5.70
自引率
6.20%
发文量
132
审稿时长
6-12 weeks
期刊介绍: A reader-friendly resource, Current Opinion in Nephrology and Hypertension provides an up-to-date account of the most important advances in the field of nephrology and hypertension. Each issue contains either two or three sections delivering a diverse and comprehensive coverage of all the key issues, including pathophysiology of hypertension, circulation and hemodynamics, and clinical nephrology. Current Opinion in Nephrology and Hypertension is an indispensable journal for the busy clinician, researcher or student.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书